FDA Approves ADAPALENE AND BENZOYL PEROXIDE — Aurobindo Pharma Limited
The FDA has granted approval to Aurobindo Pharma Limited for their generic version of adapalene and benzoyl peroxide, intensifying competition in the topical acne market. This latest authorization is expected to provide cost-effective alternatives while potentially pressuring the market share of branded prescription therapies.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed